Nautilus Biotechnology (NAUT) Total Business Assets

Nautilus Biotechnology - graphic logo of issuer NAUT

The price history of Nautilus Biotechnology (NAUT) shares demonstrates total assets at 174.92. Nautilus Biotechnology is advancing proteomics by establishing partnerships with scientific centers to accelerate the discovery of oncological targets. The business is currently focused on R&D, anticipating profitability once products enter the market. Bold bioengineers and data analysts working with cutting-edge equipment ensure the project's success.

Nautilus Bio (NAUT) Company Total Assets: for the period 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for nautilus.bio (NAUT)

- price and consensus price forecast:
Price Nautilus Bio|NAUT - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization NAUT|NAUT - Total Company Value
- book capitalization data:
Equity per Share Nautilus Biotechnology|NAUT - Book Capitalization|Market Capitalization to Book Value Ratio nautilus.bio|NAUT - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Ratio Nautilus Biotechnology|NAUT - Long-Term Debt to Capital|Short-Term Debt to Capital Nautilus Bio|NAUT - Company Total Debt|Debts to Book Capitalization NAUT|NAUT - Company Long-Term Liabilities|Amount of Current Liabilities Nautilus Biotechnology
Fundamental valuation:NAUT, Nautilus Biotechnology Inc
Manufactured product of nautilus.bio

Total assets reflect the aggregate resource potential of a business, combining equity and liabilities to assess financial stability. By analyzing the total assets calculation reverse-engineered via ROA, an investor can observe balance sheet dynamics, where for Nautilus Biotechnology (NAUT), the ratio of R&D optics expenditures to the scaling potential through recurring sales of consumable reagents is critical.

Competitor analysis

Tempus AI, Inc (TEM) - Aggregate Business Assets|Company Total Assets Qiagen (QGEN)|Total Business Assets IONS|Aggregate Company Assets Repligen Corp. RGEN|Total Business Assets Avidity Corp (RNA)|Company Total Assets CRSP (CRISPR Therapeutics AG)|genedx.com - Company Total Assets|Ultragenyx (RARE) - Aggregate Company Assets|BEAM - Total Business Assets|SRPT: Company Total Assets|Company Total Assets Twist Bioscience Corp|TXG (10x Genomics, Inc.) - Cumulative Company Assets|Company Total Assets intelliatx.com (NTLA)|Cumulative Company Assets Stoke Therapeutics, Inc.|Aggregate Business Assets BioLife Solutions Inc (BLFS)|Company Total Assets WVE|Maze Therapeutics Corp - Company Total Asset Base|SION - Aggregate Company Assets|primemedicine.com (PRME) - Aggregate Company Assets|TSHA: Cumulative Company Assets|QURE (uniQure NV) - Company Total Assets|MGTX: Aggregate Company Assets|Company Total Asset Base REGENXBIO Corp (RGNX)|Solid Biosciences Inc. (SLDB) - Cumulative Company Assets|Aggregate Asset Value ocugen.com (OCGN)|Company Total Assets PacBio PACB|Aggregate Company Assets Benitec Biopharma Inc BNTC|Company Total Assets DSGN (Design Pharma)|RCKT: Company Total Asset Base|Aggregate Company Assets FDMT|Company Assets Lexeo Therapeutics, Inc.|Korro Bio Inc. (KRRO) - Cumulative Company Assets|Aggregate Business Assets Editas Medicine Inc|Silence Therapeutics Inc. - Company Total Assets|Company Assets proqr.com (PRQR)|Codexis - Company Total Assets|Cumulative Company Assets sangamo.com SGMO|Company Total Assets Metagenomi (MGX)|DTIL: Aggregate Asset Value|Aggregate Company Assets generationbio.com|BOLD (Boundless Bio Inc) - Total Business Assets|Aggregate Company Assets XCUR (Exicure Inc.)|Company Assets IMNN|Aggregate Company Assets Phio Pharmaceuticals (PHIO)|Aggregate Company Assets MBIO (mustangbio.com)|RNAZ: Aggregate Company Assets|Company Assets Bionano Genomics Inc. BNGO|Company Total Assets APDN|bluebirdbio.com (BLUE) - Company Balance Sheet Assets|Cumulative Company Assets IPA|OMGA (Omega Therapeutics Inc) - Company Assets|Aggregate Company Assets Singular Genomics Systems Inc (OMIC)|Total Business Assets Regulus|Company Total Assets SYRS|Company Total Assets telesisbio.com TBIO|Cumulative Company Assets TCON (TRACON Pharmaceuticals, Inc.)|UBX - Company Total Assets